Caligan picks up a stake in Verona Pharma, seeing an opportunity to generate more value
Verona Pharma has seen its share price skyrocket in anticipation of the commercial launch of its COPD treatment.
| Ticker |
Sentiment |
Impact |
|
INSM
|
Somewhat Bullish
|
4 %
|
|
MPSYF
|
Neutral
|
4 %
|
|
VRNA
|
Neutral
|
19 %
|
